Aakaar Medical Technologies Limited
Bookbuilding IPO · NSE
- Price band
- ₹68 - ₹72
- Lot size
- 1,600 shares
- Issue amount
- ₹27 cr
- Total subscription
- 2.25×
- Opens
- 20 Jun 2025
- Closes
- 24 Jun 2025
- Allotment
- 25 Jun 2025
- Listing
- 27 Jun 2025
Offer at a glance
Issue overview
- Issue size
- 37,50,400 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,08,800
- Fresh issue
- ₹27 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,15,200
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,04,22,416
- Shares after issue
- 1,41,72,816
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,600 | ₹1,15,200 |
| HNI | 2 | 3,200 | ₹2,30,400 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | — | 7 |
| NIB | — | 123 |
| RETAIL | — | 1,507 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 5.13 | 17.97 |
| RETAIL | 8.99 | 17.36 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 6.13 | 3.14 | 2.36 |
| ROE | 0 | 0 | 0 |
| ROCE | 21.02 | 17.68 | 22.3 |
| RONW | 33.81 | 25.88 | 24.35 |
| PRE IPO(PE) | 12.43 | 0 | 0 |
| POST IPO(PE) | 16.9 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Aakaar Medical Technologies Limited, established in June 2013, is a company focused on aesthetic medical solutions, offering a wide range of specialized cosmetic products and devices. It primarily caters to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. The company provides both its own brands—comprising products made in India and devices produced internationally—as well as imported brands from countries like South Korea, Spain, Italy, and Austria. These products are mainly supplied to professionals who either use them during treatments or sell them to end users. Aakaar’s offerings include skincare for home and professional use, injectable and contouring products, hair care solutions such as growth serums and tablets, medifacial kits, and various medical devices. These devices are used for treatments like urinary incontinence, tattoo removal, skin rejuvenation, laser hair reduction, and hair transplants. With a presence across India, the company has a strong network of 90 trained sales and service engineers, supporting a large and satisfied customer base. It distributes its products in multiple states including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Strengths
- Strong and Experienced Leadership: Managed by industry experts with deep domain knowledge in aesthetic medicine, driving strategic growth and operational excellence.
- Diversified Product Portfolio: Offers a comprehensive range of aesthetic devices and consumables, including both in-house and imported brands, catering to varied customer needs.
- Extensive Geographic Footprint: Maintains a robust pan-India presence through direct branches and an established consignment partner network, ensuring broad market coverage and accessibility.
Risk factors
- High Dependence on Imported Products: Significant reliance on third-party international brands makes the company vulnerable to supply chain interruptions, import delays, and foreign market uncertainties.
- Reliance on Contract Manufacturers: Heavy dependence on external manufacturing partners and loan license arrangements increases exposure to risks around production consistency, quality assurance, and regulatory compliance.
- Exposure to Cost Fluctuations: Volatile prices of raw materials, utilities, and logistics may adversely affect margins, operational efficiency, and overall financial performance.
Promoters
Dilip Ramesh Meswani
Bindi Dilip Meswani
Registrar & documents
Lead manager
Indorient Financial Services Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
801, Heritage Plaza, Telli Galli Cross Road Andheri (East), Mumbai, Maharashtra, 400069
+91 84528 44024
[email protected]Company website ↗Frequently Asked Questions
What is Aakaar Medical Technologies IPO GMP today?
Currently, Aakaar Medical Technologies IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹72. Track daily updates on IPO Premiums as bidding numbers unfold.
What is the lot size and minimum investment for Aakaar Medical Technologies IPO?
The minimum bid lot size for Aakaar Medical Technologies IPO is 1,600 shares. At the cut-off price of ₹72 per share, retail investors need a minimum application amount of ₹1,15,200 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Aakaar Medical Technologies IPO allotment status be announced?
The allotment status for Aakaar Medical Technologies IPO is scheduled to be finalized on 25 Jun 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Aakaar Medical Technologies IPO allotment status online by PAN?
To check Aakaar Medical Technologies IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Aakaar Medical Technologies Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.